PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The chimeric mouse model with a humanized liver is used for in vivo studies in gene therapeutics, NASH/NAFLD drug development programs, anti-viral therapeutic tests, DMPK/toxicity studies, and custom transplantations. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
Metrics to compare | 6190 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6190PeersSector | |
---|---|---|---|---|
P/E Ratio | −4.1x | −0.3x | −0.5x | |
PEG Ratio | 0.00 | 0.05 | 0.00 | |
Price/Book | 1.4x | 1.4x | 2.6x | |
Price / LTM Sales | 1.2x | 1.6x | 3.3x | |
Upside (Analyst Target) | - | 88.3% | 43.5% | |
Fair Value Upside | Unlock | 24.1% | 6.9% | Unlock |